Jonathan Sisson Featured Image

Jonathan Sisson


Executive Medical Director, Clinical Development & Regulatory Strategy

Jon is a pharmaceutical physician with extensive knowledge of medicines development and regulation across the whole product lifecycle.

Before moving to tranScrip, he was an assessor at the UK Medicines and Healthcare Products Regulatory Agency (MHRA) for 21 years, with roles in the licencing and post-licencing divisions, assessing new and established products across multiple regulatory processes. As well as chairing and participating in scientific advice meetings at MHRA, he was a UK representative on the EU Committee for Medicinal Products for Human Use (CHMP) Scientific Advice Working Party.

Previously, following clinical training in internal medicine, he worked in the Hoechst and GlaxoWellcome clinical pharmacology units. Jon has a particular interest in clinical pharmacology, bioequivalence studies and structured benefit:risk assessment.

He is a member of the faculty of pharmaceutical medicine’s board of examiners and was previously convenor for the MCQ section of the DipPharmMed exam.

Join our team

We are always interested to hear from experienced professionals that are looking to develop their career with tranScrip.

View all vacancies

Contact our team of experts

Our physicians, scientists and service experts can help to maximise the value of your products. Whatever your project requires, we have the people to meet your needs.